Analysis of differentially expressed genes in early- and late-stage APPsw-transgenic and normal mice using cDNA microarray

International Journal of Molecular Medicine

Volumn 19, Issue 3, 2007, Pages 461-468

  Jee, Seung W ^a   Cho, Jung S ^a   Kim, Chuel K ^a   Hwang, Dae Y ^a   Shim, Sun B ^a   Lee, Su H ^a   Sin, Ji S ^a   Kim, Yang S ^b   Park, Jin H ^a   Lee, Se H ^a   Choi, Soo Y ^a   Kim, Yong K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; APPsw; cDNA microarray; Transgenic

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; C57BL MOUSE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DOWN-REGULATION; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

EID: 33947496723     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.3.461     Document Type: Article

References (53)

1. Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer's Disease. Nature 399: A23-A31, 1999. (Pubitemid 29295656)
2. Yamazaki T, Koo EH and Selkoe DJ: Trafficking of cell-surface amyloid beta-protein precursor II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization. J Cell Sci 109: 999-1008, 1996. (Pubitemid 126477168)
3. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH and Trojanowski JQ: Expression profile of transcript in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48: 77-87, 2000.
4. Pasinetti GM and Ho L: From cDNA microarrays to highthroughput proteomics: Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. Restor Neurol Neurosci 18: 137-142, 2001.
5. Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Owen MJ, Williams J, Lendon C and Rubinstein DC: Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci Lett 358: 142-146, 2004.
6. Dickey CA, Loring JF, Montgomery J, Gordon MN, Eastman PS and Morgan D: Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein+presenilin-1 transgenic mice. J Neurosci 23: 5219-5226, 2003. (Pubitemid 36793250)
7. Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY and Kim YK: Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp Neurol 186: 20-32, 2004.
8. Jee SW, Cho JS, Oh JH, Shim SB, Hwang DY, Lee SH, Song YS, Lee SH and Kim Y: cDNA microarray-based analysis of differentially expressed genes in transgenic brains expressing NSE-controlled APPsw. Int J Mol Med 16: 547-552, 2005.
9. Kinsbury GA and Junghans RP: Screening of phage display immunoglobulin libraries anti-M13 ELISA and whole phage PCR. Nucleic Acids Res 23: 2563-2564, 1995.
10. Hong SH, Nah HY, Lee JY, Gye MC, Kim CH and Kim MK: Analysis of estrogen-regulated genes in mouse uterus using cDNA microarray and laser capture microdissection. J Endocrinol 181: 157-167, 2004. (Pubitemid 38584673)
11. Tusher VG, Tibshrani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
12. Mace S, Cousin E, Ricard S, Genin E, Spanakis E, Lafargue-Soubigou C, Genin B, Fourned R, Roche S, Haussy G, Massey F, Soubigou S, Brefort G, Benoit P, Brice A, Campion D, Holls M, Pradier L, Benavides J and Delenze JF: ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. Neurobiol Dis 18: 1119-1125, 2005.
13. Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D and Frangione B: Gelsolin variant and beta-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 12: 313-316, 1991.
14. Stroombergen MC and Waring RH: Determination of glutathione S-transferase mu and theta polymorphism in neurological disease. Hum Exp Toxicol 18: 141-145, 1999. (Pubitemid 29134903)
15. Laws SM, Perneczky R, Wagenpfeil S, Muller U, Forstl H, Martins RN, Kurz A and Riemeschneider M: TNF polymorphism in Alzheimer's disease and functional implications on CSF β-amyloid levels. Hum Mutat 26: 29-35, 2005. (Pubitemid 40980700)
16. Bartzokis G: Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25: 5-18, 2004.
17. Bartzokis G, Lu PH and Mintz J: Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimer Dis 6: S53-S59, 2004.
18. Tian J, Shi J, Bailey K and Mann DM: Relationship between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 30: 46-56, 2004.
19. Mizukami K, Ikonomovic MD, Grayson DR, Sheffield R and Amstrong DM: Immunohistochemical study of GABAA receptor 1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res 799: 148-155, 1998.
20. Mills PJ, Adler KA, Dimsdale JE, Perez CJ, Ziegler MG, Ancoli-Israel S, Patterson TL and Grant I: Vulnerable caregivers of Alzheimer disease patients have a deficit in 2-adrenergic receptor sensitivity and density. Am J Geriatr Psychiatry 12: 281-286, 2004.
21. Rissman RA, Mishizen-Eberz AJ, Carter TL, Wolfe BB, De Blas AL, Miralles CP, Ikonomovic MD and Amstrong DM: Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology. Neuroscience 120: 695-704, 2003.
22. Sun MK and Alkon DL: Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 23: 83-89, 2002.
23. Wang LH, Besirli CG and Johnson EM Jr: Mixed lineage kinases: a target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol 44: 451-474, 2004.
24. Farooqui AA, Antony P, Ong WY, Hprrocks LA and Freysz L: Retinoic acid mediated phospholipase A2 signaling in the nucleus. Brain Res Rev 45: 179-195, 2004.
25. Sihag RK and Cataldo AM: Brain beta-spectrin is a component of senile plaques in Alzhemer's disease. Brain Res 743: 249-257, 1996.
26. Lovell MA, Xie C and Markesbery WR: Decreased glutathione transferase activity in brain and ventricular fluids in Alzheimer's disease. Neurology 51: 1562-1566, 1998.
27. Smith SK, Anderson HA, Yu G, Robertson AG, Allen SJ, Tyler SJ, Naylor RL, Mason G, Wicock GW, Roche PA, Frased PE and Dawbarn D: Identification of syntax 1A as a binding protein for presenilin-1. Brain Res Mol Brain Res 78: 100-107, 2000.
28. Johnston AM, Naselli G, Niwa H, Brodnick T, Harrison LC and Gonez LJ: Harp (harmonin-interacting, ankyrin repeat-containing protein), a novel protein that interacts with harmonin in epithelial tissues. Gene Cells 9: 967-982, 2004.
29. Wiedemann P, Bonisch H, Oerters F and Bruss M: Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations. J Neural Transm 109: 443-453, 2002.
30. Kochanski A, Drac H, Kabzinska D, Ryniewicz-Marcinska K, Nowakowski A and Hausmanowa-Petrusewicz I: A novel MPZ gene mutation in congenital neuropathy with hypomyelination. Neurology 62: 2122-2123, 2004.
31. Gao YQ, Danciger M, Akhmedov NB, Zhao DY, Heckenlively JR, Fishman GA, Weleber RG, Jacobson SG and Farber DB: Exon screening of the genes encoding the beta- and gamma-subunits of cone transduction in patients with inherited retinal disease. Mol Vis 4: 16, 1998.
32. Stoiber D, Kocacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kline OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M and Sexl V: TYK2 is a key regulator of the surveillance of B lymphoid tumors. J Clin Invest 114: 1650-1658, 2004.
33. Su DM and Manley NR: Stage-specific changes in fetal thymocyte proliferation during the CD4-8 to CD4+8+ transition in wild type, Rag1-/-, and Hoxa3, Pax1 mutant mice. BMC Immunol 3: 12, 2002.
34. Ballabeni A, Melixetian M, Zamponi R, Masiero L, Marinoni F and Helin K: Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis. EMBO J 23: 3122-3132, 2004.
35. Hart PE, Poynter GM, Whitehead CM, Orth JD, Glantz JN, Busby RC, Barrett SL and Salisbury JL: Characterization of the X-liked murine centrin Cetn2 gene. Gene 264: 205-213, 2001.
36. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G and Fernandes-Alnemri ES: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 57: 615-619, 1997.
37. Freeman RS, Hasbani DM, Lipscomb EA, Straub JA and Xie L: SM-20, EGL-9, and EGLN family of hypoxia-inducible factor prolyl hydroxylases. Mol Cell 16: 1-12, 2003.
38. Pan Z, Hirata Y, Nagalaj RY, Zhao J, Nishi M, Hayek SM, Bhat MB, Takeshima M and Ma J: Co-expression of MG29 and ryanodine receptor leads to apoptotic cell death: effect mediated by intracellular Ca2+ release. J Biol Chem 279: 19387-19390, 2004.
39. Qiao H, Koya RC, Nakagawa K, Tanaka H, Fugita H, Takimoto M and Kuzumaki N: Inhibition of Alzheimer's amyloid-beta peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin. Neurobiol Aging 26: 849-855, 2005.
40. Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW and Vincent I: The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am J Pathol 157: 1983-1990, 2000.
41. Xu X, Yamamoto H, Sakon M, Yasui M, Ngan CY, Fukunaga H, Morita T, Ogawa M, Nagano H, Nakamori S, Sekimoto M, Matsuura N and Monden M: Overexpression of CDC25A phosphotase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 9: 1764-1772, 2003.
42. Katoh M and Katoh M: Identification and characterization of ASXL2 in silico. Int J Oncol 23: 845-850, 2003.
43. Zhang X, Zhang H and Oherdick J: Conservation of the developmentally regulated dendritic localization of a Purkinje cell-specific mRNA that encodes a G-protein modulator: comparison of rodent and human Pep2(L7) gene structure and expression. Brain Res Mol Brain Res 105: 1-10, 2002.
44. Sadec CM, Pelto-Huikko M, Tujague M, Steffensen KR, Wennerholm M and Gustafsson JA: TACC3 expression is tightly regulated during early differentiation. Gene Exp Patterns 3: 203-211, 2003.
45. Aitola M, Sadec CM, Gustafsson JA and Pelto-Huito-Huikko M: Aint/Tacc3 is highly expressed in proliferating mouse tissues during development, spermatogenesis, and oogenesis. J Histochem Cytochem 51: 455-469, 2003.
46. Kato M, Neil TK, Clark GL, Morris CM, Sorg RV and Hart DN: cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells. Immunogenetics 47: 442-450, 1998.
47. Matsumura T, Ito A, Takii T, Hayashi H and Onozaki K: Endotoxin and cytokine regulation of toll-like receptor (TLR)2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20: 915-921, 2000.
48. Chakravarty S and Herkenham M: Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25: 1788-1796, 2005.
49. Lakkis MM, Bergenhem NC, O'Shea KS and Tashian RE: Expression of the acatalytic carbonic anhydrase VIII gene, Car8, during mouse embryonic development. J Histochem Cytochem 29: 135-141, 1997.
50. Sotirion S, Gispert S, Cheng J, Wang Y, Chen A, Hoogstraten-Miller S, Miller GF, Kwon O, Levine M, Guttentag SH and Nussbaum RL: Ascrobic-acid trasporter Sle23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med 8: 514-517, 2002.
51. Nicholson AC, Malik SB, Logsdon JM Jr and van Meir EG: Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization. BMC Evol Biol 5: 11, 2005.
52. Damer CK and Creutz CE: Synaptotagmin II expression partially rescues the growth defect of the yeast sec15 secretory mutant. Biol Cell 88: 55-63, 1996.
53. Tanaka KF, Kashima H, Suzuki H, Ono K and Sawada M: Existence of functional beta1-and beta2-adrenergic receptors on microglia. J Neurosci Res 70: 232-237, 2002.